GL1X · GenesisL1 explorer

MolNFT v1 · #122081 · protein

Structure of CDL2.2, a computationally designed vitamin-D3 binder

5IEN: “Structure of CDL2.2, a computationally designed vitamin-D3 binder”. X-ray diffraction, 1 ligand (VDY), 2 pockets (best druggability 0.74). MolNFT v1 #122081 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5IEN
Type
protein
Length
253 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
CDL2.2
Ligands
VDY
Pockets
2 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 28% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACDL2.2protein12928% helix, 47% strand—
BCDL2.2protein12429% helix, 49% strand—

Ligands and binding sites

  • VDY · 3-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7A-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexanol · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13700.740.8542VDY
23040.720.8536VDY

Interfaces

1 interface between chains.

  • A–B · 1120 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 5IEN · Structure of CDL2.2, a computationally designed Vitamin-D3 binder · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.